MetaCap

Anika Therapeutics Statistics

NASDAQ: ANIKHealth CareMedical/Dental InstrumentsUSD

13.23-0.05 (-0.38%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Anika Therapeutics by the numbers

Anika Therapeutics has a market capitalization of $177.2 million based on 13.40M shares outstanding. With trailing EPS of $-0.03, Anika Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 29.9% below its 50-day average and 19.8% below its 200-day average.

Average daily trading volume is 105.68K shares, or about $1.4 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ANIK valuation vs. peer median

ANIK compared with the median of 8 peer companies
MetricANIKPeer medianDifference
Market cap$177.22M$199.81M-11%
Avg. volume105.68K178.14K-41%

Peer median across 8 companies: UTMD, PDEX, KTWO, KRMD, CLPT, PYPD, PROF, STIM.

Valuation

Market cap
$177.22M
Price / sales (latest FY)
1.57
EPS (TTM)
$-0.03

Price and trading

Previous close
13.28
Open
13.30
Day range
12.98 – 13.70
52-week range
9.01 – 22.88
52-week change
+33.91%
Beta
—
Volume
166.48K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
177.22M
Forward Pe
13.23
Eps
-0.03
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
22.88
Week52 Low
9.01
Avg Volume
105.68K
Shares Outstanding
13.40M
Ma50
18.88
Ma200
16.50
Earnings Date
Nov 6, 2026
Pct From52w High
-42.18%
Pct From52w Low
46.84%

Related